130 related articles for article (PubMed ID: 11970991)
1. A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo.
Kelly JM; Takeda K; Darcy PK; Yagita H; Smyth MJ
J Immunol; 2002 May; 168(9):4472-9. PubMed ID: 11970991
[TBL] [Abstract][Full Text] [Related]
2. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection.
Kelly JM; Darcy PK; Markby JL; Godfrey DI; Takeda K; Yagita H; Smyth MJ
Nat Immunol; 2002 Jan; 3(1):83-90. PubMed ID: 11743585
[TBL] [Abstract][Full Text] [Related]
3. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
Hayakawa Y; Kelly JM; Westwood JA; Darcy PK; Diefenbach A; Raulet D; Smyth MJ
J Immunol; 2002 Nov; 169(10):5377-81. PubMed ID: 12421908
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway.
Westwood JA; Kelly JM; Tanner JE; Kershaw MH; Smyth MJ; Hayakawa Y
J Immunol; 2004 Jan; 172(2):757-61. PubMed ID: 14707044
[TBL] [Abstract][Full Text] [Related]
5. Distinct requirements for IFNs and STAT1 in NK cell function.
Lee CK; Rao DT; Gertner R; Gimeno R; Frey AB; Levy DE
J Immunol; 2000 Oct; 165(7):3571-7. PubMed ID: 11034357
[TBL] [Abstract][Full Text] [Related]
6. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
Takeda K; Smyth MJ; Cretney E; Hayakawa Y; Yamaguchi N; Yagita H; Okumura K
Cell Immunol; 2001 Dec; 214(2):194-200. PubMed ID: 12088418
[TBL] [Abstract][Full Text] [Related]
7. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum.
Smyth MJ; Kelly JM; Baxter AG; Körner H; Sedgwick JD
J Exp Med; 1998 Nov; 188(9):1611-9. PubMed ID: 9802973
[TBL] [Abstract][Full Text] [Related]
8. A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells.
Screpanti V; Wallin RP; Ljunggren HG; Grandien A
J Immunol; 2001 Aug; 167(4):2068-73. PubMed ID: 11489989
[TBL] [Abstract][Full Text] [Related]
9. Perforin dependence of natural killer cell-mediated tumor control in vivo.
van den Broek MF; Kägi D; Zinkernagel RM; Hengartner H
Eur J Immunol; 1995 Dec; 25(12):3514-6. PubMed ID: 8566046
[TBL] [Abstract][Full Text] [Related]
10. Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor control.
Pardo J; Balkow S; Anel A; Simon MM
Eur J Immunol; 2002 Oct; 32(10):2881-7. PubMed ID: 12355441
[TBL] [Abstract][Full Text] [Related]
11. T cell-mediated tumor rejection displays diverse dependence upon perforin and IFN-gamma mechanisms that cannot be predicted from in vitro T cell characteristics.
Peng L; Krauss JC; Plautz GE; Mukai S; Shu S; Cohen PA
J Immunol; 2000 Dec; 165(12):7116-24. PubMed ID: 11120842
[TBL] [Abstract][Full Text] [Related]
12. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
Immunology; 2006 Aug; 118(4):483-96. PubMed ID: 16895556
[TBL] [Abstract][Full Text] [Related]
13. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.
Lee SH; Bar-Haim E; Machlenkin A; Goldberger O; Volovitz I; Vadai E; Tzehoval E; Eisenbach L
Cancer Gene Ther; 2004 Mar; 11(3):237-48. PubMed ID: 14739939
[TBL] [Abstract][Full Text] [Related]
14. Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.
Street SE; Cretney E; Smyth MJ
Blood; 2001 Jan; 97(1):192-7. PubMed ID: 11133760
[TBL] [Abstract][Full Text] [Related]
15. Perforin is required for innate and adaptive immunity induced by heat shock protein gp96.
Strbo N; Oizumi S; Sotosek-Tokmadzic V; Podack ER
Immunity; 2003 Mar; 18(3):381-90. PubMed ID: 12648455
[TBL] [Abstract][Full Text] [Related]
16. IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma.
Ma HL; Whitters MJ; Konz RF; Senices M; Young DA; Grusby MJ; Collins M; Dunussi-Joannopoulos K
J Immunol; 2003 Jul; 171(2):608-15. PubMed ID: 12847225
[TBL] [Abstract][Full Text] [Related]
17. Differential involvement of CD40, CD80, and major histocompatibility complex class I molecules in cytotoxicity induction and interferon-gamma production by human natural killer effectors.
Terrazzano G; Zanzi D; Palomba C; Carbone E; Grimaldi S; Pisanti S; Fontana S; Zappacosta S; Ruggiero G
J Leukoc Biol; 2002 Aug; 72(2):305-11. PubMed ID: 12149421
[TBL] [Abstract][Full Text] [Related]
18. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
Austin Taylor M; Bennett M; Kumar V; Schatzle JD
J Immunol; 2000 Nov; 165(9):5048-53. PubMed ID: 11046034
[TBL] [Abstract][Full Text] [Related]
19. NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-γ and perforin-dependent mechanisms.
Ge MQ; Ho AW; Tang Y; Wong KH; Chua BY; Gasser S; Kemeny DM
J Immunol; 2012 Sep; 189(5):2099-109. PubMed ID: 22869906
[TBL] [Abstract][Full Text] [Related]
20. Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity.
Davis JE; Smyth MJ; Trapani JA
Eur J Immunol; 2001 Jan; 31(1):39-47. PubMed ID: 11169436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
